This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: Innovations by Hector Aguilar in Diabetes Treatment
Introduction
Hector Aguilar is an accomplished inventor based in San Antonio, TX (US). He has made significant contributions to the field of diabetes treatment, holding a total of 2 patents. His work focuses on innovative methods for inducing insulin synthesis and secretion from pancreatic beta cells.
Latest Patents
One of Hector Aguilar's latest patents is centered around Isoxazole treatments for diabetes. This invention relates to compounds and methods that can induce the synthesis and secretion of insulin from pancreatic beta cells. The methods described may take place in vitro, ex vivo, or in vivo, and the compounds may find use in the treatment of diabetes. This innovative approach has the potential to improve the lives of those affected by this chronic condition.
Career Highlights
Hector Aguilar is affiliated with The University of Texas System, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective solutions for diabetes management.
Collaborations
Hector collaborates with notable colleagues such as Jay Schneider and Doug E Frantz, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Hector Aguilar's contributions to diabetes treatment through his innovative patents highlight his dedication to improving healthcare outcomes. His work exemplifies the impact of research and collaboration in the field of medical science.